![Cynthia Carnes](/sites/default/files/styles/person_500x500/public/uploads/images/Cynthia%20Carnes.jpeg?h=2a479378&itok=poWPQSu3)
Cynthia Carnes, PharmD, PhD
Professor
My research is focused on cardiac arrhythmias (abnormal heart rhythms), particularly in heart failure. We use an integrated approach from proteins to cells to tissues to the intact organism to study the causes, and potential treatments of cardiac arrhythmias. My clinical practice is at the Ambulatory Care Center at the Ross Heart Hospital, where I provide patient care in antiarrhythmic medication monitoring.
Other research areas:
Cardiovascular Disorders
![Razi Kebriaei](/sites/default/files/styles/person_500x500/public/uploads/images/Razi%20Kebriaei.jpeg?h=2a479378&itok=fWRzAmmY)
Razi Kebriaei, PhD
Assistant Professor
Dr. Kebriaei’s research is focused on treatment of multi-drug resistant bacterial infections. Some examples of the diseases associated with these infections include bacteremia, endocarditis, bone and joint infections and implant associated infections.
Her current work is concentrated on both planktonic and biofilm states of bacteria and novel approaches for combating multi-drug resistant infections. She utilizes various classes of antimicrobials with distinct mechanisms of action to discover optimal treatment options for a wide range of infectious diseases. In addition, she designs and operates pharmacokinetic/pharmacodynamic models to simulate humanized doses in vitro. The majority of knowledge achieved from this research is translatable to bedside and leads to better patient outcomes.
Her current work is concentrated on both planktonic and biofilm states of bacteria and novel approaches for combating multi-drug resistant infections. She utilizes various classes of antimicrobials with distinct mechanisms of action to discover optimal treatment options for a wide range of infectious diseases. In addition, she designs and operates pharmacokinetic/pharmacodynamic models to simulate humanized doses in vitro. The majority of knowledge achieved from this research is translatable to bedside and leads to better patient outcomes.
Other research areas:
Infectious Diseases
![Junan Li](/sites/default/files/styles/person_500x500/public/uploads/images/Junan%20Li.jpeg?h=2a479378&itok=80GAxzED)
![Marjorie Neidecker](/sites/default/files/styles/person_500x500/public/uploads/images/Marjorie%20Neidecker.jpeg?h=2a479378&itok=iCmWvRij)
Marjorie Neidecker, PhD, MEng, RN, CCRP
Assistant Professor - Clinical
Dr. Neidecker’s research interests include pharmacoeconomic analyses and health outcomes studies. Her scholarship also focuses on clinical research education and workforce development. She has experience in curriculum development and program evaluation, and she enjoys serving as a research project advisor for students in the MS Health Systems Pharmacy Administration and Leadership program.
![Jen Plahovinsak](/sites/default/files/styles/person_500x500/public/uploads/images/Jen%20Plahovinsak.jpeg?h=2a479378&itok=Ounya6lB)
Jen Plahovinsak
Director MS Translational Pharmacology Program
Professor Jennifer (Jen) Plahovinsak is the Director of the Master of Science in Translational Pharmacology program. Jen’ s research focuses on the design and development of technology-enhanced learning environments for science education, graphic and instructional design to support learning, key learner characteristics for graduate students, curricular development for online toxicology courses, and quality strategies for online program success. Additionally, her interests include the development of relevant preclinical models to support medical countermeasure research programs. Jen has been certified as a Diplomate of the American Board of Toxicology since 2015.
Other research areas:
Scholarship of Teaching and Learning
![Przemyslaw Radwański](/sites/default/files/styles/person_500x500/public/uploads/images/Przemyslaw%20Radwanski.jpeg?h=2a479378&itok=kZ6YSxA9)
Przemyslaw Radwański, PharmD, PhD
Associate Professor
Research in the Radwański lab focuses on cardiac biophysics and pharmacology with the twin goals of understanding the mechanisms of life-threatening abnormal heart beats (cardiac arrhythmias), and developing effective antiarrhythmic therapies. By leveraging experience as both a clinical pharmacist and a cardiovascular researcher, and using cutting-edge biophysical approaches ranging from the single-ion channel level to the whole organism, they have identified a novel arrhythmia mechanism. Neuronal-type sodium channels account for a tiny fraction of sodium channels in the heart, but exert a disproportionately strong influence on cardiac calcium dynamics, particularly in disease. By applying pharmacology principles, in the context of this fundamental insight, they are developing novel therapeutic approaches, which effectively prevent arrhythmias, while avoiding the lethal side effects usually associated with classical antiarrhythmic agents. In essence, Dr. Radwański’s approach could be summarized as better clinical outcomes through basic scientific insights.
Other research areas:
Cardiovascular Disorders
![Marcia Worley](/sites/default/files/styles/person_500x500/public/uploads/images/Marcia%20Worley.jpeg?h=2a479378&itok=OiEl0FfC)
Marcia Worley, PhD, RPh, FAPhA
Professor
Other research areas:
Medication Use & Outcomes